Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.
Significant progress has been made in Hepatitis C virus (HCV) culture since the JFH1 strain cloning. However, developing efficient and physiologically relevant culture systems for all viral genotypes remains an important goal. In this work, we aimed at producing a high titer JFH1 derived virus to test different hepatic cells' permissivity. To this end, we performed successive infections and obtained a JFH1 derived virus reaching high titers. Six potential adaptive mutations were identified (I599V in E2, R1373Q and M1611T in NS3, S2364P and C2441S in NS5A and R2523K in NS5B) and the effect of these mutations on HCV replication and infectious particle production was investigated. This cell culture adapted virus enabled us to efficiently infect primary human hepatocytes, as demonstrated using the RFP-NLS-IPS reporter protein and intracellular HCV RNA quantification. However, the induction of a strong type III interferon response in these cells was responsible for HCV inhibition. The disruption of this innate immune response led to a strong infection enhancement and permitted the detection of viral protein expression by western blotting as well as progeny virus production. This cell culture adapted virus also enabled us to easily compare the permissivity of seven hepatoma cell lines. In particular, we demonstrated that HuH-7, HepG2-CD81, PLC/PRF/5 and Hep3B cells were permissive to HCV entry, replication and secretion even if the efficiency was very low in PLC/PRF/5 and Hep3B cells. In contrast, we did not observe any infection of SNU-182, SNU-398 and SNU-449 hepatoma cells. Using iodixanol density gradients, we also demonstrated that the density profiles of HCV particles produced by PLC/PRF/5 and Hep3B cells were different from that of HuH-7 and HepG2-CD81 derived virions. These results will help the development of a physiologically relevant culture system for HCV patient isolates.
EA4294, Laboratoire de Virologie, Centre Hospitalier Universitaire et Université de Picardie Jules Verne, Amiens, France.
Francois
F
Helle
Etienne
E
Brochot
Carole
C
Fournier
Véronique
V
Descamps
Laure
L
Izquierdo
Thomas W
TW
Hoffmann
Virginie
V
Morel
Yves-Edouard
YE
Herpe
Abderrahmane
A
Bengrine
Sandrine
S
Belouzard
Czeslaw
C
Wychowski
Jean
J
Dubuisson
Catherine
C
Francois
Jean-Marc
JM
Regimbeau
Sandrine
S
Castelain
Gilles
G
Duverlie
D000222:Adaptation, Physiological / Q000235:genetics; D006528:Carcinoma, Hepatocellular; D004252:DNA Mutational Analysis; D056945:Hep G2 Cells; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D054884:Host-Pathogen Interactions; D006801:Humans; D007113:Immunity, Innate; D009154:Mutation; D061251:Primary Cell Culture; D012367:RNA, Viral / Q000235:genetics; D019562:Viral Load; D014776:Virus Cultivation; D053586:Virus Internalization
D012367:RNA, Viral